Alterations in the metabolic signature of full-term infants of diabetic mothers

Background Maternal diabetes during pregnancy may alter the metabolomic profile of the offspring, increasing the risk of perinatal complications and potentially predisposing them to adverse metabolic consequences during later life. To assess this risk, we aimed to study the levels of amino acids and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Egyptian Journal of Medical Human Genetics 2024-12, Vol.25 (1), p.152
Hauptverfasser: Awad, Hesham A., Gad, Ghada I., Khalifa, Ola A., Ibrahim, Amal A., Shinkar, Dina M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 152
container_title Egyptian Journal of Medical Human Genetics
container_volume 25
creator Awad, Hesham A.
Gad, Ghada I.
Khalifa, Ola A.
Ibrahim, Amal A.
Shinkar, Dina M.
description Background Maternal diabetes during pregnancy may alter the metabolomic profile of the offspring, increasing the risk of perinatal complications and potentially predisposing them to adverse metabolic consequences during later life. To assess this risk, we aimed to study the levels of amino acids and acylcarnitines in the cord blood of infants of diabetic mothers (IDMs). Methods Fifty term-IDMs were compared to 25 healthy newborns. Of the diabetic mothers, 37 had gestational diabetes mellitus (GDM), and 13 had pre-gestational diabetes mellitus (PGDM). Amino acid and acylcarnitine concentrations were measured in dried spot samples of cord blood using ultra-performance liquid chromatography–mass spectrometry (UPLC-MS). Results We observed significantly higher levels of valine, aspartic acid, the leucine-to-isoleucine (Leu:Ile), and leucine-to-phenylalanine (Leu:Phe), and decreased values of methionine and the phenylalanine-to-tyrosine (Phe:Tyr) in neonates in the GDM group compared to controls. Neonates of mothers with GDM showed higher levels of C2-carnitine, C5-carnitine, C5:1, and C4-OH (C3-DC) compared to controls. Neonates of mothers with PGDM also showed higher levels of C2-carnitine, C0-carnitine, and C5:1 compared to controls. There were no significant differences in amino acids or acylcarnitine levels between IDMs with GDMs and PGDMs. Principle component analysis (PCA) showed that principal component 1 (PC1) was responsible for the majority of differences between IDMs and controls. PC1 consisted of aspartic, valine, leu:lle, C4-OH(C3-DC), C2-carnitine, C0-carinitine, C5-carnitine, C18:1, and C16:1. Variable importance in projection (VIP) scores based on PLS-DA loadings showed high values for aspartic, valine, leu:lle, Leu:Phe, C4-OH(C3-DC), C2-carnitine, C0-carnitine, C5:1, C5-DC, C18:1, C16:1, C5-carnitine in IDMs, and high values for Met:Phe, methionine, and Phe:Tyr in controls. Conclusion Maternal diabetes leads to alterations in amino acid concentrations and the carnitine shuttle pathway of their offspring.
doi_str_mv 10.1186/s43042-024-00615-1
format Article
fullrecord <record><control><sourceid>proquest_sprin</sourceid><recordid>TN_cdi_proquest_journals_3147280575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3147280575</sourcerecordid><originalsourceid>FETCH-LOGICAL-p721-abbd1557d77c700248e387a87fe89044f340e981349cd608afd4c13142a1c1473</originalsourceid><addsrcrecordid>eNpF0MtqwzAQBVBRWmia9ge6MnStdkYaW_IyhL4gkE32Qral1MGxU0n-_ypNoauB4cyDy9gjwjOirl4iSSDBQRAHqLDkeMUWAmrgggiv2QIRgetKwi27i_GQUSkVLdh2NSQXbOqnMRb9WKQvVxxdss009G0R-_1o0xxcMfnCz8PAMz5m5-2Y4rnZ9bZxKdPjlEdDvGc33g7RPfzVJdu9ve7WH3yzff9crzb8pARy2zQdlqXqlGoV5K-1k1pZrbzTNRB5SeBqjZLqtqtAW99RixJJWGyRlFyyp8vaU5i-ZxeTOUxzGPNFk5USGkpVZiUvKp5CP-5d-FcI5hycuQRn8gvmNziD8gcIcmAE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147280575</pqid></control><display><type>article</type><title>Alterations in the metabolic signature of full-term infants of diabetic mothers</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Awad, Hesham A. ; Gad, Ghada I. ; Khalifa, Ola A. ; Ibrahim, Amal A. ; Shinkar, Dina M.</creator><creatorcontrib>Awad, Hesham A. ; Gad, Ghada I. ; Khalifa, Ola A. ; Ibrahim, Amal A. ; Shinkar, Dina M.</creatorcontrib><description>Background Maternal diabetes during pregnancy may alter the metabolomic profile of the offspring, increasing the risk of perinatal complications and potentially predisposing them to adverse metabolic consequences during later life. To assess this risk, we aimed to study the levels of amino acids and acylcarnitines in the cord blood of infants of diabetic mothers (IDMs). Methods Fifty term-IDMs were compared to 25 healthy newborns. Of the diabetic mothers, 37 had gestational diabetes mellitus (GDM), and 13 had pre-gestational diabetes mellitus (PGDM). Amino acid and acylcarnitine concentrations were measured in dried spot samples of cord blood using ultra-performance liquid chromatography–mass spectrometry (UPLC-MS). Results We observed significantly higher levels of valine, aspartic acid, the leucine-to-isoleucine (Leu:Ile), and leucine-to-phenylalanine (Leu:Phe), and decreased values of methionine and the phenylalanine-to-tyrosine (Phe:Tyr) in neonates in the GDM group compared to controls. Neonates of mothers with GDM showed higher levels of C2-carnitine, C5-carnitine, C5:1, and C4-OH (C3-DC) compared to controls. Neonates of mothers with PGDM also showed higher levels of C2-carnitine, C0-carnitine, and C5:1 compared to controls. There were no significant differences in amino acids or acylcarnitine levels between IDMs with GDMs and PGDMs. Principle component analysis (PCA) showed that principal component 1 (PC1) was responsible for the majority of differences between IDMs and controls. PC1 consisted of aspartic, valine, leu:lle, C4-OH(C3-DC), C2-carnitine, C0-carinitine, C5-carnitine, C18:1, and C16:1. Variable importance in projection (VIP) scores based on PLS-DA loadings showed high values for aspartic, valine, leu:lle, Leu:Phe, C4-OH(C3-DC), C2-carnitine, C0-carnitine, C5:1, C5-DC, C18:1, C16:1, C5-carnitine in IDMs, and high values for Met:Phe, methionine, and Phe:Tyr in controls. Conclusion Maternal diabetes leads to alterations in amino acid concentrations and the carnitine shuttle pathway of their offspring.</description><identifier>ISSN: 1110-8630</identifier><identifier>EISSN: 2090-2441</identifier><identifier>DOI: 10.1186/s43042-024-00615-1</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Amino acids ; Aspartic acid ; Blood levels ; Body mass index ; Carnitine ; Cord blood ; Diabetes mellitus ; Infants ; Isoleucine ; Liquid chromatography ; Mass spectroscopy ; Medicine ; Medicine &amp; Public Health ; Metabolites ; Metabolomics ; Methionine ; Neonates ; Obesity ; Offspring ; Phenylalanine ; Pregnancy complications ; Principal components analysis ; Valine ; Womens health</subject><ispartof>Egyptian Journal of Medical Human Genetics, 2024-12, Vol.25 (1), p.152</ispartof><rights>The Author(s) 2024</rights><rights>Copyright Springer Nature B.V. Dec 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Awad, Hesham A.</creatorcontrib><creatorcontrib>Gad, Ghada I.</creatorcontrib><creatorcontrib>Khalifa, Ola A.</creatorcontrib><creatorcontrib>Ibrahim, Amal A.</creatorcontrib><creatorcontrib>Shinkar, Dina M.</creatorcontrib><title>Alterations in the metabolic signature of full-term infants of diabetic mothers</title><title>Egyptian Journal of Medical Human Genetics</title><addtitle>Egypt J Med Hum Genet</addtitle><description>Background Maternal diabetes during pregnancy may alter the metabolomic profile of the offspring, increasing the risk of perinatal complications and potentially predisposing them to adverse metabolic consequences during later life. To assess this risk, we aimed to study the levels of amino acids and acylcarnitines in the cord blood of infants of diabetic mothers (IDMs). Methods Fifty term-IDMs were compared to 25 healthy newborns. Of the diabetic mothers, 37 had gestational diabetes mellitus (GDM), and 13 had pre-gestational diabetes mellitus (PGDM). Amino acid and acylcarnitine concentrations were measured in dried spot samples of cord blood using ultra-performance liquid chromatography–mass spectrometry (UPLC-MS). Results We observed significantly higher levels of valine, aspartic acid, the leucine-to-isoleucine (Leu:Ile), and leucine-to-phenylalanine (Leu:Phe), and decreased values of methionine and the phenylalanine-to-tyrosine (Phe:Tyr) in neonates in the GDM group compared to controls. Neonates of mothers with GDM showed higher levels of C2-carnitine, C5-carnitine, C5:1, and C4-OH (C3-DC) compared to controls. Neonates of mothers with PGDM also showed higher levels of C2-carnitine, C0-carnitine, and C5:1 compared to controls. There were no significant differences in amino acids or acylcarnitine levels between IDMs with GDMs and PGDMs. Principle component analysis (PCA) showed that principal component 1 (PC1) was responsible for the majority of differences between IDMs and controls. PC1 consisted of aspartic, valine, leu:lle, C4-OH(C3-DC), C2-carnitine, C0-carinitine, C5-carnitine, C18:1, and C16:1. Variable importance in projection (VIP) scores based on PLS-DA loadings showed high values for aspartic, valine, leu:lle, Leu:Phe, C4-OH(C3-DC), C2-carnitine, C0-carnitine, C5:1, C5-DC, C18:1, C16:1, C5-carnitine in IDMs, and high values for Met:Phe, methionine, and Phe:Tyr in controls. Conclusion Maternal diabetes leads to alterations in amino acid concentrations and the carnitine shuttle pathway of their offspring.</description><subject>Amino acids</subject><subject>Aspartic acid</subject><subject>Blood levels</subject><subject>Body mass index</subject><subject>Carnitine</subject><subject>Cord blood</subject><subject>Diabetes mellitus</subject><subject>Infants</subject><subject>Isoleucine</subject><subject>Liquid chromatography</subject><subject>Mass spectroscopy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolites</subject><subject>Metabolomics</subject><subject>Methionine</subject><subject>Neonates</subject><subject>Obesity</subject><subject>Offspring</subject><subject>Phenylalanine</subject><subject>Pregnancy complications</subject><subject>Principal components analysis</subject><subject>Valine</subject><subject>Womens health</subject><issn>1110-8630</issn><issn>2090-2441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpF0MtqwzAQBVBRWmia9ge6MnStdkYaW_IyhL4gkE32Qral1MGxU0n-_ypNoauB4cyDy9gjwjOirl4iSSDBQRAHqLDkeMUWAmrgggiv2QIRgetKwi27i_GQUSkVLdh2NSQXbOqnMRb9WKQvVxxdss009G0R-_1o0xxcMfnCz8PAMz5m5-2Y4rnZ9bZxKdPjlEdDvGc33g7RPfzVJdu9ve7WH3yzff9crzb8pARy2zQdlqXqlGoV5K-1k1pZrbzTNRB5SeBqjZLqtqtAW99RixJJWGyRlFyyp8vaU5i-ZxeTOUxzGPNFk5USGkpVZiUvKp5CP-5d-FcI5hycuQRn8gvmNziD8gcIcmAE</recordid><startdate>20241219</startdate><enddate>20241219</enddate><creator>Awad, Hesham A.</creator><creator>Gad, Ghada I.</creator><creator>Khalifa, Ola A.</creator><creator>Ibrahim, Amal A.</creator><creator>Shinkar, Dina M.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20241219</creationdate><title>Alterations in the metabolic signature of full-term infants of diabetic mothers</title><author>Awad, Hesham A. ; Gad, Ghada I. ; Khalifa, Ola A. ; Ibrahim, Amal A. ; Shinkar, Dina M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p721-abbd1557d77c700248e387a87fe89044f340e981349cd608afd4c13142a1c1473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amino acids</topic><topic>Aspartic acid</topic><topic>Blood levels</topic><topic>Body mass index</topic><topic>Carnitine</topic><topic>Cord blood</topic><topic>Diabetes mellitus</topic><topic>Infants</topic><topic>Isoleucine</topic><topic>Liquid chromatography</topic><topic>Mass spectroscopy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolites</topic><topic>Metabolomics</topic><topic>Methionine</topic><topic>Neonates</topic><topic>Obesity</topic><topic>Offspring</topic><topic>Phenylalanine</topic><topic>Pregnancy complications</topic><topic>Principal components analysis</topic><topic>Valine</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awad, Hesham A.</creatorcontrib><creatorcontrib>Gad, Ghada I.</creatorcontrib><creatorcontrib>Khalifa, Ola A.</creatorcontrib><creatorcontrib>Ibrahim, Amal A.</creatorcontrib><creatorcontrib>Shinkar, Dina M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Egyptian Journal of Medical Human Genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awad, Hesham A.</au><au>Gad, Ghada I.</au><au>Khalifa, Ola A.</au><au>Ibrahim, Amal A.</au><au>Shinkar, Dina M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in the metabolic signature of full-term infants of diabetic mothers</atitle><jtitle>Egyptian Journal of Medical Human Genetics</jtitle><stitle>Egypt J Med Hum Genet</stitle><date>2024-12-19</date><risdate>2024</risdate><volume>25</volume><issue>1</issue><spage>152</spage><pages>152-</pages><issn>1110-8630</issn><eissn>2090-2441</eissn><abstract>Background Maternal diabetes during pregnancy may alter the metabolomic profile of the offspring, increasing the risk of perinatal complications and potentially predisposing them to adverse metabolic consequences during later life. To assess this risk, we aimed to study the levels of amino acids and acylcarnitines in the cord blood of infants of diabetic mothers (IDMs). Methods Fifty term-IDMs were compared to 25 healthy newborns. Of the diabetic mothers, 37 had gestational diabetes mellitus (GDM), and 13 had pre-gestational diabetes mellitus (PGDM). Amino acid and acylcarnitine concentrations were measured in dried spot samples of cord blood using ultra-performance liquid chromatography–mass spectrometry (UPLC-MS). Results We observed significantly higher levels of valine, aspartic acid, the leucine-to-isoleucine (Leu:Ile), and leucine-to-phenylalanine (Leu:Phe), and decreased values of methionine and the phenylalanine-to-tyrosine (Phe:Tyr) in neonates in the GDM group compared to controls. Neonates of mothers with GDM showed higher levels of C2-carnitine, C5-carnitine, C5:1, and C4-OH (C3-DC) compared to controls. Neonates of mothers with PGDM also showed higher levels of C2-carnitine, C0-carnitine, and C5:1 compared to controls. There were no significant differences in amino acids or acylcarnitine levels between IDMs with GDMs and PGDMs. Principle component analysis (PCA) showed that principal component 1 (PC1) was responsible for the majority of differences between IDMs and controls. PC1 consisted of aspartic, valine, leu:lle, C4-OH(C3-DC), C2-carnitine, C0-carinitine, C5-carnitine, C18:1, and C16:1. Variable importance in projection (VIP) scores based on PLS-DA loadings showed high values for aspartic, valine, leu:lle, Leu:Phe, C4-OH(C3-DC), C2-carnitine, C0-carnitine, C5:1, C5-DC, C18:1, C16:1, C5-carnitine in IDMs, and high values for Met:Phe, methionine, and Phe:Tyr in controls. Conclusion Maternal diabetes leads to alterations in amino acid concentrations and the carnitine shuttle pathway of their offspring.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1186/s43042-024-00615-1</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1110-8630
ispartof Egyptian Journal of Medical Human Genetics, 2024-12, Vol.25 (1), p.152
issn 1110-8630
2090-2441
language eng
recordid cdi_proquest_journals_3147280575
source DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals
subjects Amino acids
Aspartic acid
Blood levels
Body mass index
Carnitine
Cord blood
Diabetes mellitus
Infants
Isoleucine
Liquid chromatography
Mass spectroscopy
Medicine
Medicine & Public Health
Metabolites
Metabolomics
Methionine
Neonates
Obesity
Offspring
Phenylalanine
Pregnancy complications
Principal components analysis
Valine
Womens health
title Alterations in the metabolic signature of full-term infants of diabetic mothers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T13%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20the%20metabolic%20signature%20of%20full-term%20infants%20of%20diabetic%20mothers&rft.jtitle=Egyptian%20Journal%20of%20Medical%20Human%20Genetics&rft.au=Awad,%20Hesham%20A.&rft.date=2024-12-19&rft.volume=25&rft.issue=1&rft.spage=152&rft.pages=152-&rft.issn=1110-8630&rft.eissn=2090-2441&rft_id=info:doi/10.1186/s43042-024-00615-1&rft_dat=%3Cproquest_sprin%3E3147280575%3C/proquest_sprin%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3147280575&rft_id=info:pmid/&rfr_iscdi=true